Logo image of ZYNE

ZYNERBA PHARMACEUTICALS INC (ZYNE) Stock Analyst Ratings

USA - NASDAQ:ZYNE - US98986X1090 - Common Stock

1.3 USD
+0.03 (+2.36%)
Last: 10/10/2023, 8:00:03 PM
1.3015 USD
+0 (+0.12%)
After Hours: 10/10/2023, 8:00:03 PM
Buy % Consensus

49

ChartMill assigns a Buy % Consensus number of 49% to ZYNE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.28. This target is -1.53% below the current price.
ZYNE was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about ZYNE.
In the previous month the buy percentage consensus was at a similar level.
ZYNE was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

ZYNE Historical Analyst RatingsZYNE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -82 -74 -66 -58 -50 -42 -34 -26 -18 -10 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.301.121.281.281.47 - -13.76% -1.53% -1.53% 13.08%

Related screens

ZYNE Current Analyst RatingZYNE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2023-08-16 Canaccord Genuity Downgrade Buy -> Hold
2023-08-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-06-23 Canaccord Genuity Maintains Buy